Association between MDM2-SNP309 and hepatocellular carcinoma in Taiwanese population

Table 3 Estimation of odds ratio for different genotypes of MDM2-SNP309 in hepatitis viral infected patients with HCC n (%)

Hepatitis1	SNP309	Cases	Controls	OR2	95% CI	P value
Positive	TT	7 (14.3)	1 (10)	1.000
	TG	32 (65.3)	7 (70)	2.340	0.11-49.655	0.59
	GG	10 (20.4)	2 (20)	2.568	0.054-121.687	0.63
	TG+GG	42 (85.7)	9 (90)	2.376	0.115-48.896	0.57
Negative	TT	4 (44.4)	19 (24)	1.000
	TG	5 (55.6)	45 (57)	0.512	0.046-5.712	0.59
	GG3	0 (0)	15 (19)	-	-	-
	TG+GG	5 (55.6)	60 (76)	0.470	0.041-5.387	0.54

¹Include HBV or HCV infected patients with HCC;

²OR was adjusted for age, gender and cardiovascular diseases and/or diabetes;

³OR was not estimated because the number in case was zero.